Drawing for Serial No. 87422710

USPTO serial 87422710

Serial No. 87422710

Reviewed by CopyMark Law Group

Reg. 5342782Status 702Renewal
Filing date
Status date
Registration date
Nov 21, 2017
Examiner
PRATER, JILL I
Law office
TMO LAW OFFICE 119

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with Serial No. 87422710?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq. Troutman Pepper Locke LLP875 Third Avenuec/o IP Services NYCNew York, NY 10022

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in oncologyACTIVEMay 9, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 30, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 30, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 30, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 1, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 1, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 1, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 21, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Nov 21, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 27, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 27, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 27, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 27, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 27, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 1, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 1, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 1, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 1, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 29, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 22, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 14, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 21, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 20, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 19, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 16, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 16, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 25, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 25, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 12, 2017IUAFUSE AMENDMENT FILED—
Sep 12, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 29, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 4, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 4, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 14, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 24, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 23, 2017DOCKASSIGNED TO EXAMINER—
May 2, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 1, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 27, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance